We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

ASTM Workshop on Measurement of Elemental Contaminants in Cannabis/Hemp Consumer Products

This workshop will provide a broad perspective of the current knowledge of elemental contaminants in cannabis/hemp consumer products, communicate their significance, and as a result, educate users, cultivators, processors, testing labs, and regulators within the cannabis/hemp community of their potential risk to human and environmental health.

Read More

Cancer Patients Get Sleep Benefits From Medical Cannabis, Finds Study

In a new study, many cancer patients reported significant improvements in sleep disruptions and a decreased use of other medication for insomnia.

Read More

Celebrating Science on 420

Analytical Cannabis mark 420 by sharing some of our favourite cannabis content in bite-sized segments.

Read More

Nevada Considers Removing Label Requirement for Radiation-Treated Cannabis

The Nevada Cannabis Compliance Board (CCB) are considering changes to its state cannabis regulations which would remove the requirement for cannabis treated with irradiation to display the international symbol for irradiation, the Radura.

Read More

Oklahoma Cannabis Testing Lab Loses License

State authorities in Oklahoma have revoked the license of a medical cannabis testing lab on the grounds of public health and safety.

Read More

Cannabis Users With Genetic Markers for Schizophrenia Are More Likely to Have Psychotic Episodes, Study Finds

The paper found that, while cannabis consumers have higher rates of psychotic experiences than non-consumers, the difference was indeed more pronounced among those with a high genetic predisposition to schizophrenia.

Read More

New Research Sheds Light on How Long Cannabis Impairment Lasts

In a new meta-analysis of past cannabis impairment studies, researchers at the University of Sydney have identified a “window of impairment” following medium and high-dose cannabis use, during which users should avoid driving.

Read More

Psilocybin Compared to Antidepressant in Breakthrough Trial

A new trial has directly compared the antidepressant effects of psilocybin with a more classical antidepressant, and found that the two are matched in their mood-altering potential.

Read More

Cannabis Advertising Linked to Problematic Use in Teens, Study Claims

Teens who frequently see billboard or storefront advertising for recreational cannabis products are more likely to use the drug weekly and to have symptoms of cannabis use disorder, according to new research.

Read More

 
Advertisement